Track latest semaglutide clinical trials, GLP-1 agonist studies, and peptide research trials. Access FDA-approved trials, randomized controlled studies, and pharmaceutical research breakthroughs shaping evidence-based medicine.
Multi-center study examining long-term efficacy and safety of semaglutide for chronic weight management in adults with obesity.
Body Protection Compound-157 (BPC-157) is a pentadecapeptide with demonstrated cytoprotective and regenerative properties. This study investigates the...
Regenerative MedicineIF: 4.2
Retatrutide represents breakthrough peptide therapy as a novel triple receptor agonist targeting GLP-1, GIP, and glucagon receptors. This randomized c...
New England Journal of MedicineIF: 176.1
This large-scale observational study analyzed cardiovascular outcomes in 45,678 patients with metabolic syndrome treated with GLP-1 receptor agonists...
CirculationIF: 37.8
Clinical trials are research studies that test new medical treatments, drugs, or devices in people. They are the primary way researchers find out if a new treatment is safe and effective. All trials listed here are for informational purposes only. Always consult with healthcare professionals before considering participation in any clinical trial.